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Background and objective: To evaluate the level of pain during phacoemulsification and 
foldable intraocular lens implantation under instillation of tetracaine 0.5% eyedrops versus a 
combination of lidocaine 2% gel and instillation of tetracaine eyedrops.
Methods: This prospective, randomized, controlled study included 51 patients undergoing 
phacoemulsification under topical anesthesia. They were randomized into two groups based 
on the topical anesthetic method they were to receive. Preoperatively all patients were asked to 
answer a questionnaire. One hour postoperatively, they were asked to grade their intraoperative 
and postoperative pain on a visual analog scale from 0 to 10.
Results: There were no statistically significant differences between the two methods of anes-
thesia. Gender and the presence of relatives or friends were independent factors playing a 
significant role in pain sensitivity.
Conclusions: The combination of lidocaine 2% gel and tetracaine eyedrops does not have a 
better analgesic result than a single instillation of tetracaine 0.5% eyedrops.
Keywords: ophthalmic pain, cataract, phacoemulsification, tetracaine eyedrops, lidocaine gel, 
topical anesthesia
Introduction
Cataract remains the most common cause of blindness in the developing world.1 Pha-
coemulsification cataract surgery is one of the most commonly performed elective 
surgical procedures in Europe and the US. More than 99% of cataract operations in 
the UK are now treated using this technique.2 It is anticipated that a further 225,000 
new cases of visually significant cataract will be treated every year in the UK. In the 
US, more than one million cataract operations are performed per year.3 More than 
3000 of these procedures are performed every year using phacoemulsification at the 
University Hospital of Ioannina in Greece.
Because cataract surgery has developed into a rapid turnover day case procedure, 
the options for anesthesia have also evolved. There are currently several options for 
cataract surgery anesthesia.4 Topical anesthesia for phacoemulsification was first 
described by Fichman in 1992.5 Topical anesthesia is widely accepted in cataract 
procedures, and has become the first choice in most cases of planned routine cataract 
surgery.6,7 This has found wide acceptance, especially in the US, where it is used 
by 61% of cataract surgeons (up from 8% in 1995, 51% in 2000) particularly those 
undertaking high-volume surgery.8 This type of anesthesia does not have the injection-
related complications of retrobulbar or peribulbar anesthesia, reduces surgical costs, 
and increases patient satisfaction.9,10 However, careful patient selection is important, Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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and the technique may not be suitable for uncooperative and 
anxious patients. Operating under topical anesthesia also 
requires an experienced and highly skilled surgeon.11
Topical anesthetics can be used as drops, gel, or intracam-
eral injection in cataract surgery. The most frequently used 
agent for topical anesthesia is tetracaine 0.5% eyedrops which 
are safe and effective in most cases.10 Some patients report 
intraoperative and/or postoperative pain and discomfort after 
instillation of tetracaine eyedrops as topical anesthesia.12,13
The clinical efficacy of lidocaine 2% gel has been evalu-
ated in different studies, all of which have reported that the 
gel is safe and provides good pain control in most cases.14,15 
Gel anesthesia with lidocaine 2% has shown higher intra-
cameral levels of lidocaine, better analgesia, better patient 
cooperation, and less need for intraoperative analgesia than 
lidocaine 4% topical drops.16
In this study, we compared and evaluated the efficacy of 
tetracaine 0.5% eyedrops and the combination of lidocaine 
2% gel application and instillation of tetracaine 0.5% eye-
drops as methods of topical anesthesia during phacoemulsi-
fication and one hour postoperatively.
Methods
Approval for the study was obtained from the hospital ethics 
committee. All patients received a thorough explanation of 
the study design and aim, and signed an informed consent.
This prospective, controlled, randomized, single-center, 
clinical trial included 51 patients scheduled for planned 
routine cataract surgery, ie, phacoemulsification with 
intraocular lens implantation, from May 2008 to July 2008. 
The exclusion criteria were Alzheimer’s disease, psychologic 
and mental disorders, reported allergy to topical anesthetic 
agent, and the use of analgesic medications in the three days 
before surgery.
Preoperatively, all patients received a routine ophthalmic 
checkup consisting of visual acuity, anterior chamber and 
fundus examination, measurement of intraocular pressure, 
and biometry for the selection of the correct lens implant. 
Patients were randomly allocated to one of two groups, 
using sealed number envelopes that contained the name 
of the anesthetic to be administered. One group received 
0.5 cm lidocaine 2% gel plus one drop of tetracaine 0.5%, 
while the other group received only one drop of tetracaine 
0.5%. Starting 15 minutes prior to surgery, anesthetics were 
applied every five minutes in the conjunctival fornices. Both 
patients and the surgical assistant who collected the data were 
blinded to which anesthetic agent was given. No patient had 
simultaneous bilateral surgery. All patients received a tablet 
of haloperidol orally one hour before the surgery. No patient 
received preoperative or intraoperative sedation.
All patients had routine monitoring of arterial oxygen 
saturation, electrocardiography, and blood pressure, as well 
as intravenous access fashioned before the administration 
of anesthetic. Mydriasis was obtained preoperatively using 
phenylephrine hydrochloride 10% and tropicamide 0.5%. 
Phacoemulsifications were performed by one experienced 
surgeon using the same technique of temporal and clear 
corneal incision. Foldable intraocular lenses were implanted. 
If the patient reported marked pain or discomfort during the 
surgery, supplemental topical anesthesia of two drops of 
tetracaine was administered.
Preoperatively, all patients were asked to answer a ques-
tionnaire, which was devised specifically for the study in the 
form of an verbal interview. The aim of this questionnaire was 
to collect information about factors which could influence 
the evaluation of pain. All patients were asked about their 
everyday medications and about any pain-relieving medica-
tions that they may occasionally take. We also thought that it 
could be useful to know if the patients had had any previous 
experience of cataract surgery, and if they were accompanied 
to the hospital by friends and/or relatives.
Immediately after the completion of surgery, patients 
were asked to grade their pain on a visual analog scale (VAS, 
0 = no pain, 10 = severe unbearable pain) intraoperatively 
(VAS1) and postoperatively approximately one hour after the 
surgery (VAS2). The patients were also asked to differenti-
ate the characteristics of pain or discomfort. Data recorded 
included eye conditions and systemic diseases, age, gender, 
and whether the patient was escorted to the hospital by friends 
and relatives. The Student’s t-test was used to compare the 
groups for statistical purposes.
Results
Fifty-one patients, aged 51–86 years, were included in the 
study. Twenty-seven patients (53%) were randomized to 
receive tetracaine eyedrops and 24 (47%) to receive com-
bined tetracaine eyedrops and lidocaine gel. In our sample, 
31% had had eye surgery in the past. Forty-seven percent of 
Table 1 The statistically important variables correlating with 
intraoperative pain
Parameter Estimate Standard  
error
95% confidence interval
Lower limit Upper limit
Constant 3.684 0.858 1.959 5.408
gender -2.557 0.567 -3.698 -1.417
Company 1.981 0.823 0.327 3.636Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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the patients were taking analgesic medication occasionally 
for different reasons. No patient in either treatment group 
reported a pain score of 10. During surgery, a pain score 
of 8 was reached by two patients in the tetracaine eyedrops 
group and by three in the combined tetracaine eyedrops and 
lidocaine gel group, and supplemental topical anesthesia of 
two drops of tetracaine was administered in these patients. 
Five patients in the first group had a pain score of 0 after 
surgery, as did nine in the second group. However, this dif-
ference between the two different methods of anesthesia was 
not statistically significant (Table 2). The results of the t-test 
for the comparison of the two techniques of anesthesia are 
shown in Table 3. The pain score one hour after surgery was 
40% lower than the pain score during phacoemulsification.
Two parameters for which the differences were statisti-
cally significant were gender and the presence of relatives 
or friends at the hospital. Men (27/51, 52.9%) reported less 
pain than did women in both the treatment groups. It was 
interesting to note that patients from both groups who were 
accompanied by friends or relatives (44/51, 86.3%) reported 
more pain (Table 1). There were no statistically significant 
differences between the treatment groups with regard to 
patient age, education level, eye conditions, systemic dis-
eases, and habitual use of analgesics.
Discussion
Our results show that both tetracaine 0.5% eyedrops alone 
and the combination of tetracaine 0.5% eyedrops plus 
lidocaine 2% gel have good anesthetic properties for topical 
use in cataract surgery. However, no statistically significant 
difference in pain scores during surgery or postoperatively 
was observed between the two groups (Table 1).
Similar results have been reported previously in the 
literature. Barequet et al also reached the conclusion that 
lidocaine 2% was comparable with tetracaine 0.5% eyedrops 
in provision of corneal anesthesia. They also found that a 
single application of one quarter inch of gel gave pain scores 
equivalent to three doses of tetracaine eyedrops.16 Amiel et al 
compared the anesthetic effect of the two drugs and concluded 
that their effects were similar.17 These studies were limited by 
the absence of standardization in the quality of pain reported 
by the patients, because no validated pain assessment tool 
such as the VAS was used. On the other hand, studies like 
the one by Irle et al18 showed that the effect of instillation of 
tetracaine 0.5% eyedrops is better than that of lidocaine 2% gel 
application during cataract surgery, but leaving unanswered 
questions about the ideal method of topical anesthesia.
Interestingly, although the present study does not dem-
onstrate a significant improvement in pain scores by adding 
lidocaine gel to the usual regimen of tetracaine eye drops, 
it does show a statistically significant difference in pain 
sensitivity between men and women. Men reported less 
pain than women during their cataract surgery and postop-
eratively. Similar results were previously demonstrated in 
the Graven-Nielsen study for a difference in pain sensitivity 
between men and women, as well as a gender-dependent 
Table 3 Results of t-test for comparison of the two methods of anesthesia. The difference does not result in a statistically significant 
result
Levene’s 
test  
for equality  
of variances
t-test for equality of means
F Sig. t df Sig. (2-tailed) Mean 
difference
Std. error 
difference
95% confidence 
interval of the 
difference
Lower Upper
VAs1   equal variance assumed 
equal variance not assumed
0.783 0.381 0.439 
0.435
49 
45.505
0.663 
0.666
0.310 
0.310
0.706 
0.713
-1.109 
-1.126
1.730 
1.746
VAs2   equal variance assumed 
equal variance not assumed
0.001 0.975 -1.024 49 0.311 -0.472 0.461 -1.399 0.455
-1.022 47.991 0.312 -0.472 0.462 -1.401 0.457
Table 2 intraoperative pain and postoperative pain for the two methods of anesthesia
Anesthesia n Mean Standard deviation Standard error mean
intraoperative pain Tetracaine eyedrops 
Tetracaine drops + lidocaine gel
27 
24
4.19 
3.88
2.321 
2.724
0.447 
0.556
Postoperative  
pain
Tetracaine eyedrops 
Tetracaine drops + lidocaine gel
27 
24
1.11 
1.58
1.625 
1.666
0.313 
0.340Clinical Ophthalmology
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response to pharmacologic interventions, eg, opioids and 
nonsteroidal anti-inflammatory drugs.19
Another outcome of our study concerns the relationship 
between pain sensitivity and the presence of accompanying 
friends and/or relatives. Contrary to what one would expect, 
patients accompanied by relatives or friends reported more 
pain than patients who came alone to the hospital. A literature 
review makes similar observations concerning chronic pain, 
and it seems that family relationships may have an etiologic 
role in chronic pain.20,21
In conclusion, the combination of lidocaine 2% gel 
and tetracaine 0.5% eyedrops does not have a better 
analgesic effect than a single instillation of tetracaine 
0.5% eyedrops. Tetracaine 0.5% eyedrops have very good 
efficacy for pain control during phacoemulsification and 
postoperatively.
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